Blockade of subthalamic dopamine D1 receptors elicits akinesia in rats
- PMID: 9926857
- DOI: 10.1097/00001756-199812210-00020
Blockade of subthalamic dopamine D1 receptors elicits akinesia in rats
Abstract
The role of dopamine in the subthalamic nucleus to control motor behaviour was investigated in rats using bilateral microinfusions of the dopamine D1 receptor antagonist SCH23390 and the dopamine D2 receptor antagonist S(-)-sulpiride. Selective blockade of subthalamic D1 receptors, but not of D2 receptors, produced catalepsy. These findings suggest that dopamine D1 receptors within the subthalamic nucleus play a prominent role in the regulation of motor functions. Furthermore, the data point to the possibility that a reduced dopaminergic tone at subthalamic dopamine D1 receptors might contribute to akinesia in Parkinson's disease.
Similar articles
-
Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat.Behav Brain Res. 1999 Dec;106(1-2):143-50. doi: 10.1016/s0166-4328(99)00102-3. Behav Brain Res. 1999. PMID: 10595430
-
Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.Eur J Neurosci. 2001 Oct;14(8):1287-93. doi: 10.1046/j.0953-816x.2001.01759.x. Eur J Neurosci. 2001. PMID: 11703457
-
Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.Eur J Pharmacol. 1993 Mar 2;232(2-3):247-53. doi: 10.1016/0014-2999(93)90781-c. Eur J Pharmacol. 1993. PMID: 8385618
-
Dopaminergic and cholinergic interaction in cataleptic responses in mice.Pharmacol Biochem Behav. 1997 Sep;58(1):103-8. doi: 10.1016/s0091-3057(96)00478-9. Pharmacol Biochem Behav. 1997. PMID: 9264077
-
Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.J Neural Transm (Vienna). 1997;104(4-5):341-62. doi: 10.1007/BF01277656. J Neural Transm (Vienna). 1997. PMID: 9295170 Review.
Cited by
-
SCH 23390: the first selective dopamine D1-like receptor antagonist.CNS Drug Rev. 2001 Winter;7(4):399-414. doi: 10.1111/j.1527-3458.2001.tb00207.x. CNS Drug Rev. 2001. PMID: 11830757 Free PMC article. Review.
-
Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease.Front Aging Neurosci. 2014 May 13;6:87. doi: 10.3389/fnagi.2014.00087. eCollection 2014. Front Aging Neurosci. 2014. PMID: 24860498 Free PMC article. Review.
-
Extrastriatal dopaminergic circuits of the Basal Ganglia.Front Neuroanat. 2010 Oct 27;4:139. doi: 10.3389/fnana.2010.00139. eCollection 2010. Front Neuroanat. 2010. PMID: 21103009 Free PMC article.
-
Localization and function of dopamine receptors in the subthalamic nucleus of normal and parkinsonian monkeys.J Neurophysiol. 2014 Jul 15;112(2):467-79. doi: 10.1152/jn.00849.2013. Epub 2014 Apr 23. J Neurophysiol. 2014. PMID: 24760789 Free PMC article.
-
Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants.J Neurosci. 2001 May 15;21(10):3521-30. doi: 10.1523/JNEUROSCI.21-10-03521.2001. J Neurosci. 2001. PMID: 11331381 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources